Ginkgo Bioworks Holdings Inc
NYSE:DNA
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Price:
0.8034 USD
-4.24%
Market Closed
Updated:
May 17, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-1.7
Current
-2.2
Median
13.8
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-1.7
Enterprise Value
/
827.1m
EBITDA
-473m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
1.6B USD | -1.7 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
79.1B USD | 20.9 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
11.7T JPY | 10.7 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
66.7B USD | 22.9 | |
| CH |
|
Sika AG
SIX:SIKA
|
45.1B CHF | 23 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
38.5B CHF | 28.7 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
282.8B CNY | 17.6 | |
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
33.2B USD | 13.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.7T INR | 35 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
31.5B USD | 12.8 | |
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
28.6B EUR | 33.8 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
-2
2-Years Forward
EV/EBITDA
-2.6
3-Years Forward
EV/EBITDA
-3.3
You don't have any saved screeners yet
